Angel Biotechnology Holdings Plc, formerly known as Lanstop plc, is a United Kingdom-based holding company. The Company, along with its subsidiaries, is engaged in the manufacture and supply of biologics, which are biological products whose active ingredients cannot be chemically synthesized. Angel Biotechnology Holdings Plc manufactures and supplies clinical grade materials for use in its client's drug development work. The Company provides specialist solutions for cell-based therapies, such as stem cells. Angel Biotechnology Holdings Plc supplies the biopharmaceuticals contract manufacturing sector of the biologics market and within that sector is focusing on the early stage drug development work, such as chemistry, manufacturing and controls (CMC) and pre-clinical studies, along with drug products for Phases I, II and III of clinical trials. The Company acquired Angel Biotechnology Limited on July 20, 2005. |
